-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of current income tax expense (benefit) pertaining to taxable income (loss) from continuing operations.
-
Summary
-
Reviva Pharmaceuticals Holdings, Inc. annual Current Income Tax Expense (Benefit) history and growth rate from 2021 to 2023.
- Reviva Pharmaceuticals Holdings, Inc. annual Current Income Tax Expense (Benefit) for 2023 was $16.9 K, a 18.4% decline from 2022.
- Reviva Pharmaceuticals Holdings, Inc. annual Current Income Tax Expense (Benefit) for 2022 was $20.8 K, a 160% increase from 2021.
Current Income Tax Expense (Benefit), Annual (USD)
Current Income Tax Expense (Benefit), YoY Annual Growth (%)